Komori
M&A and Subsidiary Changes9633TOKYO THEATRES COMPANY,INCORPORATEDReal estate

Notice Concerning the Appointment of Members to the Special Committee under the Policy for Responding to Large-Scale Purchases of the Company's Shares (Takeover Response Policy)

In connection with the Special Committee established under the Takeover Response Policy, 3 outside directors were appointed as new committee members upon expiration of the previous members' terms.

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

This transaction

Appointment of Special Committee Members
Date of board resolution26 June 2026
Procedures and assumptions
Special CommitteeEstablished. The committee has 3 members: Inoyama Yuou (猪山 雄央), Ozawa Naoki (小澤 直樹), and Baba Kiyoshi (馬場 清). Each is an outside director of the Company and has been reported to the Tokyo Stock Exchange as an Independent Officer.
This transaction
ItemDetails
Transaction nameAppointment of Special Committee Members
Date of board resolution26 June 2026
Special CommitteeEstablished. The committee has 3 members: Inoyama Yuou (猪山 雄央), Ozawa Naoki (小澤 直樹), and Baba Kiyoshi (馬場 清). Each is an outside director of the Company and has been reported to the Tokyo Stock Exchange as an Independent Officer.
Items this document does not state (29)
Counterparty nameName of the Subject CompanyBusiness Description of the Subject CompanyLocation of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredVoting rights ownership percentageFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Impact on Business PerformanceContract DateExecution Date / Effective DateValuation methodologyIndependent valuation institutionConditions Precedent to ExecutionManagement structure after acquisition

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The 1-year terms of the Special Committee members expired.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Appointment of Members to the Special Committee under the Policy for Responding to Large-Scale Purchases of the Company's Shares (Takeover Response Policy) | TOKYO THEATRES COMPANY,INCORPORATED (9633) timely disclosure | Komori